| Product Code: ETC7645122 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Arteriovenous Malformations (AVMs) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Arteriovenous Malformations (AVMs) Market - Industry Life Cycle |
3.4 Israel Arteriovenous Malformations (AVMs) Market - Porter's Five Forces |
3.5 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Arteriovenous Malformations (AVMs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of arteriovenous malformations (AVMs) in Israel |
4.2.2 Technological advancements in the diagnosis and treatment of AVMs |
4.2.3 Growing healthcare infrastructure and investments in Israel |
4.3 Market Restraints |
4.3.1 High treatment costs associated with AVM management |
4.3.2 Limited awareness about AVMs among the general population in Israel |
4.3.3 Stringent regulatory requirements for AVM treatment devices and procedures |
5 Israel Arteriovenous Malformations (AVMs) Market Trends |
6 Israel Arteriovenous Malformations (AVMs) Market, By Types |
6.1 Israel Arteriovenous Malformations (AVMs) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By True Arteriovenous Malformation, 2021- 2031F |
6.1.4 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Occult or Cryptic, 2021- 2031F |
6.1.5 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Cavernous Malformations, 2021- 2031F |
6.1.6 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Venous Malformation, 2021- 2031F |
6.1.7 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hemangioma, 2021- 2031F |
6.1.8 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Dural Fistula, 2021- 2031F |
6.2 Israel Arteriovenous Malformations (AVMs) Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage I (Quiescence), 2021- 2031F |
6.2.3 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage II (Expansion), 2021- 2031F |
6.2.4 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage III (Destruction), 2021- 2031F |
6.2.5 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage IV (Decompensation), 2021- 2031F |
6.2.6 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Arteriovenous Malformations (AVMs) Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.3.3 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.4 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.5 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Arteriovenous Malformations (AVMs) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Arteriovenous Malformations (AVMs) Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 Israel Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Arteriovenous Malformations (AVMs) Market Import-Export Trade Statistics |
7.1 Israel Arteriovenous Malformations (AVMs) Market Export to Major Countries |
7.2 Israel Arteriovenous Malformations (AVMs) Market Imports from Major Countries |
8 Israel Arteriovenous Malformations (AVMs) Market Key Performance Indicators |
8.1 Number of AVM cases diagnosed annually in Israel |
8.2 Adoption rate of advanced AVM treatment technologies in healthcare facilities |
8.3 Rate of healthcare investments specifically directed towards AVM management in Israel |
9 Israel Arteriovenous Malformations (AVMs) Market - Opportunity Assessment |
9.1 Israel Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Israel Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Arteriovenous Malformations (AVMs) Market - Competitive Landscape |
10.1 Israel Arteriovenous Malformations (AVMs) Market Revenue Share, By Companies, 2024 |
10.2 Israel Arteriovenous Malformations (AVMs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here